Vimarsana
Biggest News Aggregation in the World

Page 11 - Adverse Effects News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adverse Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adverse Effects Today - Breaking & Trending Today

In Refractory IBD, Combination Tx Appears Safe, Effective - Vimarsana News

In Refractory IBD, Combination Tx Appears Safe, Effective

In the treatment of IBD, combinations of biologics or a biologic and tofacitinib appeared to be generally safe and effective, according to a new systematic review and meta-analysis.

Mood Interventions May Reduce IBD Inflammation - Vimarsana News

Mood Interventions May Reduce IBD Inflammation

Mood interventions, especially psychological therapies, could provide an alternative treatment for IBD that is both effective and low cost.

Gut Signature for Treatment-Resistant Schizophrenia? - Vimarsana News

Gut Signature for Treatment-Resistant Schizophrenia?

Adults with resistant schizophrenia have significant gut microbiome differences vs their counterparts who respond to treatment, a new finding that may be driven by clozapine treatment.

Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals - Vimarsana News

Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals

SALT LAKE CITY, Feb. 2, 2024 /PRNewswire/ -- Lipocine Inc. , a biopharmaceutical company focused on treating Central Nervous System disorders, today announced that commercialization of TLANDO® in...

The Solution to a 'Common and Hazardous' Symptom of BPD? - Vimarsana News

The Solution to a 'Common and Hazardous' Symptom of BPD?

Recent research highlighted the potential role of an atypical antipsychotic to treat anxiety — a prevalent and undertreated symptom in BPD that comes without the typical metabolic side effects.